Top Pharmaceuticals companies in Saudi Arabia by Price to Earnings Ratio (P/E)

This ranking features the top 13 Pharmaceuticals companies in Saudi Arabia ranked by Price to Earnings Ratio (P/E), averaging a Price to Earnings Ratio (P/E) of 18.89, for January 15, 2025.
#
Name
Price to Earnings Ratio (P/E)
Reported Date
Stock Price
Change
Price (30 days) Country
1

159.32

Jan. 14, 2025 USD 8.51 -0.30%

Saudi Arabia

2

132.83

Jan. 14, 2025 USD 15.96 0.01%

Saudi Arabia

3

51.07

Jan. 14, 2025 USD 79.48 0.76%

Saudi Arabia

4

44.22

Jan. 14, 2025 USD 2.55 1.28%

Saudi Arabia

5

42.51

Jan. 14, 2025 USD 41.76 2.90%

Saudi Arabia

6

33.90

Jan. 14, 2025 USD 53.63 2.87%

Saudi Arabia

7

26.86

Jan. 14, 2025 USD 23.52 1.86%

Saudi Arabia

8

22.11

Jan. 14, 2025 USD 11.16 0.61%

Saudi Arabia

9

20.02

Jan. 14, 2025 USD 20.64 1.45%

Saudi Arabia

10

17.37

Jan. 14, 2025 USD 31.76 1.20%

Saudi Arabia

11

12.60

Jan. 14, 2025 USD 23.81 0.35%

Saudi Arabia

12

-31.40

Jan. 14, 2025 USD 9.94 0.96%

Saudi Arabia

13

-285.78

Jan. 14, 2025 USD 8.71 -2.08%

Saudi Arabia

Frequently Asked Questions
  • Which Pharmaceuticals company in Saudi Arabia has the highest Price to Earnings Ratio (P/E) ?

    The Pharmaceuticals company in Saudi Arabia with the highest Price to Earnings Ratio (P/E) is Basic Chemical Industries Company (Saudi Stock Exchange: 1210.SR) at 159.32.

  • Which Pharmaceuticals company in Saudi Arabia has the lowest Price to Earnings Ratio (P/E) ?

    The Pharmaceuticals company in Saudi Arabia with the lowest Price to Earnings Ratio (P/E) is Saudi Pharmaceutical Industries and Medical Appliances Corporation (Saudi Stock Exchange: 2070.SR) at -285.78.